We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
Cap. Flow
-$193M
Cap. Flow %
-3.9%
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$33.6M
2
AMZN icon
Amazon
AMZN
+$32.3M
3
CEB
CEB Inc.
CEB
+$27.7M
4
GILD icon
Gilead Sciences
GILD
+$27.3M
5
MRK icon
Merck
MRK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.16%
2 Financials 16.84%
3 Consumer Discretionary 14.26%
4 Technology 13.32%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ATOS icon
526
Atossa Therapeutics
ATOS
$29M
$8K ﹤0.01%
4
– –
2015 Q2
1 quarter
QMM
527
DELISTED
QUATERRA RESOURCES INC LTD
QMM
$8K ﹤0.01%
136,175
– –
2013 Q2
9 quarters
HK
528
DELISTED
Halcon Resources Corporation
HK
$8K ﹤0.01%
87
– –
2015 Q2
1 quarter
GMO
529
DELISTED
General Moly, Inc.
GMO
$4K ﹤0.01%
13,518
– –
2013 Q2
9 quarters
ACTG icon
530
Acacia Research
ACTG
$413M
– –
-12,440
Closed -$109K –
ADSK icon
531
Autodesk
ADSK
$50.1B
– –
-4,314
Closed -$216K –
ASHR icon
532
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.33B
– –
-14,650
Closed -$674K –
BHC icon
533
Bausch Health
BHC
$2.36B
– –
-1,050
Closed -$233K –
BKD icon
534
Brookdale Senior Living
BKD
$2.41B
– –
-31,260
Closed -$1.08M –
BMO icon
535
Bank of Montreal
BMO
$116B
– –
-3,462
Closed -$205K –
CLDX icon
536
Celldex Therapeutics
CLDX
$2.16B
– –
-749
Closed -$283K –
COR icon
537
Cencora
COR
$65.1B
– –
-2,855
Closed -$304K –
CPA icon
538
Copa Holdings
CPA
$5.43B
– –
-27,578
Closed -$2.28M –
CSIQ icon
539
Canadian Solar
CSIQ
$666M
– –
-15,700
Closed -$449K –
CSV icon
540
Carriage Services
CSV
$575M
– –
-31,704
Closed -$757K –
ESPR icon
541
DELISTED
Esperion Therapeutics
ESPR
– –
-2,963
Closed -$242K –
EWS icon
542
iShares MSCI Singapore ETF
EWS
$1.46B
– –
-8,258
Closed -$208K –
FCX icon
543
Freeport-McMoran
FCX
$99.9B
– –
-49,467
Closed -$921K –
FUN icon
544
Cedar Fair
FUN
$830M
– –
-4,423
Closed -$241K –
FXI icon
545
iShares China Large-Cap ETF
FXI
$3.89B
– –
-10,415
Closed -$480K –
GLPI icon
546
Gaming and Leisure Properties
GLPI
$11.4B
– –
-6,000
Closed -$220K –
GS icon
547
Goldman Sachs
GS
$257B
– –
-1,048
Closed -$219K –
HOG icon
548
Harley-Davidson
HOG
$2.78B
– –
-3,767
Closed -$212K –
IBB icon
549
iShares Biotechnology ETF
IBB
$10.3B
– –
-4,725
Closed -$581K –
IHF icon
550
iShares US Healthcare Providers ETF
IHF
$1.42B
– –
-20,150
Closed -$576K –

Similar funds

Geneva Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.

  • Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
  • Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
  • Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
  • Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
  • Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
  • Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
  • Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.

Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.